https://www.selleckchem.com/pr....oducts/gunagratinib.
experienced to be useful in the pediatric cases, where anatomical variability and rarity of the pathologies make surgery more challenging. While conventional statistical approaches have been used to identify risk factors for cerebrospinal fluid (CSF) shunt failure, these methods may not fully capture the complex contribution of clinical, radiologic, surgical, and shunt-specific variables influencing this outcome. Using prospectively collected data from the Hydrocephalus Clinical Research Network (HCRN) patient registry, we applied